San Diego Biotech
Biotech Directory
- Home
- 2011
- 2011 BIO International Convention
- 2012
- 2012 BIO International Convention
- 4SC AG
- AB Science
- Abbie Celniker
- Abbott
- Abbott Labs
- Abraxis Pharmaceutical
- academic partnership
- AcelRx
- Acetylon Pharmaceuticals
- Achaogen
- Ache
- Acheflan
- Achillion
- Achillion Pharmaceuticals
- aclidinium bromide
- Actelion
- Actos
- acute lymphoblastic leukemia
- Adasuve
- Adcetris
- Addex Pharmaceuticals
- Adnexus Therapeutics
- Advair
- advanced biofuel
- advanced biofuels
- Advanced Cell Technology
- Advanstar
- Advertising
- Affymax
- affymetrix
- Afinitor
- Aflibercept
- Agency Insight
- Agios Pharmaceuticals
- agriculture
- Agriculture Secretary Tom Vilsack
- Alan Frazier
- alcohol dependence
- Aldagen
- Alex Denner
- Alexion Pharmaceuticals
- Alexza Pharmaceuticals
- Algeta
- Alkermes
- Allozyne
- Almirall
- ALN-PCS
- Alnara Pharmaceuticals
- Alnylam Pharmaceuticals
- Alpharadin
- ALS
- Altea Therapeutics
- Altheos
- Alzheimer's
- Amarin
- America Invents Act
- Amgen
- AMR101
- Amylin pharmaceuticals
- Anaeropharma Science
- Andrew Witty
- Anemia drugs
- Animal biotechnology
- animal testing
- Anna Protopapas
- antibiotic
- antibodies
- antidepressant
- antisense
- apixaban
- Apple
- approval
- Aranesp
- Aratana Therapeutics
- ARCA
- Arena Pharmaceuticals
- arGEN-X
- Ariad Pharmaceuticals
- Arikace
- Arizona
- ARPA-E
- ArQule
- ART-123
- Asahi Kasei Pharma
- ASCO
- Asia
- Astellas
- Astellas Pharma
- Astex Therapeutics
- AstraZeneca
- Atlas Venture
- Atossa Genetics
- atrial fibrillation
- ATS907
- Aubagio
- AUTM
- autoimmune disease
- Avandia
- Avastin
- AVEO Pharmaceuticals
- AVI Biopharma
- aviation biofuels
- Avila Therapeutics
- AVL-292
- AX200
- axitinib
- AZD1446
- BA058
- backlogs
- bacteria
- Bahija Jallal
- bapineuzumab
- Barack Obama
- bardoxolone
- basal cell carcinoma
- Baxter International
- BayBio
- Bayer
- Bayer Healthcare
- BD
- Benefits of biotech crops
- Benlysta
- Bernard Munos
- betrixaban
- Bexsero
- BG Medicine
- BG-12
- Biden
- Big Pharma
- Bill and Melinda Gates Foundation
- BIND Biosciences
- BIO
- BIO Asia
- BIO CEO
- BIO CEO & Investor Conference
- BIO Events
- BIO International Convention
- Biocartis
- BIOCOM
- Biocon
- Biocryst
- BioDelivery Sciences
- bioethics
- biofuel
- Biofuel Technology
- biofuels
- Biofuels & Climate Change
- Biogen Idec
- BioGENEius
- bioindustry
- bioinformatics
- BiolineRx
- Biologics
- BioMarin Pharmaceutical
- biomarkers
- biomedical industry
- biomedical innovation
- BioMerieux
- Bionomics
- Bionor Pharma
- biopharm
- biopharma companies
- biopharma industry
- biopharmaceuticals
- biopharmceutical
- biorefineries
- biorefinery map
- BioSante Pharmaceuticals
- bioscience
- biosimilar
- biosimilars
- Biotech CEO
- Biotech deals
- biotech drugs
- Biotech graveyard
- biotech industry
- Biotech IPO
- biotech jobs
- Biotech Patenting
- Biotech policy makers
- biotech regulation
- Biotech Venture Capital
- Biotechnology
- biotechnology company
- Biotechnology Industry
- Biotechnology Industry Organization
- biotechnology institute
- biotechnology investment
- biotechnology R&D
- biotechnology research
- biotechs
- bioterror
- BioTie Therapies
- Bipolar disorder
- Blend Therapeutics
- blinatumomab
- blindness
- blockbusters
- Blog
- blood cancer
- blood clots
- blood pressure
- Bloomberg
- Boehringer Ingelheim
- Boston
- brain disease
- brain disorder
- Brazil
- breast cancer
- Bridion
- Bristol-Myers Squibb
- BTG
- BTK
- business
- Business and Investments
- business development
- Business of Biotech
- Bydureon
- Cadila Healthcare
- Cadila Pharmaceuticals
- California
- California Healthcare Institute
- Caltech
- Calypso Medical Technologies
- campus
- Canaan Partners
- Cancer
- Cancer Drugs
- Cancer Research UK
- cancer stem cells
- cancer treatments
- cancer vaccine
- capital
- Capricor
- carfilzomib
- Cariprazine
- Carl Icahn
- Carver
- Catabasis Pharmaceuticals
- CDX-110
- Celera
- Celgene
- celiac disease
- Cell Therapeutics
- Celladon
- Celldex Therapeutics
- cellulosic
- cellulosic biofuel
- cellulosic waiver credit
- Cempra Pharmaceuticals
- CEO
- CEO and Investor Conference
- Cephalon
- Cerulean Pharma
- Charles River
- Chelsea Therapeutics
- Chi-Med
- China
- cholesterol
- cholesterol drug
- Chris Viehbacher
- Christoph Westphal
- Christopher Viehbacher
- chronic lymphocytic leukemia
- Civitas Therapeutics
- CK-2017357
- climate change
- clinical trial
- Clinical Trial Results
- Clinical Trials
- Clive Morris
- Clovis Oncology
- CNS disease
- Collegium Pharmaceutical
- Colorado
- Columbia Laboratories
- combo drug
- commercialization
- communications
- Companies
- companion diagnostics
- company snapshots
- comparative effectiveness
- compliance
- Compulsory Licensing
- Concert Pharmaceuticals
- CONFIRM study
- congress
- Constellation Pharma
- Consumer Price Index
- contract research organizations
- Contrave
- convention
- Copaxone
- COPD
- Corcept Therapeutics
- Cornell
- Corporate
- Corporate Responsibility
- Council of State Bioscience Associations
- Counterfeits
- CRO
- CrystalGenomics
- CSBA
- CSC
- Cubist Pharmaceuticals
- CureVac
- Curis
- Cymbalta
- cystic fibrosis
- CYT387
- cytokinetics
- Cytomedix
- Czech Republic
- daclizumab
- Dacogen
- Dainippon Sumitomo
- dalcetrapid
- Dana-Farber Cancer Institute
- dapagliflozin
- data protection
- David Baltimore
- deal
- Deals
- Dendreon
- Department of Justice
- Depomed
- depression
- development
- development costs
- Diabetes
- Diagnostics
- Diamyd
- Dimebon
- Discovery
- diversity
- diversity summit
- DNA
- Dna Sequencing
- Dr. Cheryl Martin
- Dr. Patrick Soon-Shiong
- Dr. Steven Nissen
- Droxidopa
- Drug approvals
- drug combination
- drug data
- drug delivery systems
- drug development
- drug prices
- drugs
- Duchenne muscular dystrophy
- Durect
- E-Media
- eBioscience
- economic development
- economic growth
- economy
- education
- Eisai
- Elan
- electrofuels
- Elevation Pharmaceuticals
- Eli Lilly
- Elias Zerhouni
- Eliquis
- Ember Therapeutics
- embryonic stem cells
- EMEA
- Emergent BioSolutions
- emergin g markets
- Emerging Companies
- Emerging Markets
- employment
- Emtriva
- Enanta
- Endo Pharmaceuticals
- Endocyte
- Enobia Pharma
- EntreMed
- Environmental & Industrial
- environmental protection agency
- Enzon Pharmaceuticals
- EPA
- epigenetics
- Epizyme
- Epogen
- Europe
- European Commission
- Events
- EXC 001
- Excaliard Pharmaceuticals
- Exelixis
- exhibit hall
- Eyetech
- Eylea
- Farmer Gene
- farmers
- FDA
- FDA approval
- FDA expert panels
- federal policy
- Fibromyalgia
- finance
- Flagship Ventures
- flibanserin
- Florida
- Fluidigm
- FoldIt
- FoldRx Pharmaceuticals
- Food And Agriculture
- Food and Drug Administration
- Forbion Capital Partners
- forecast
- Forest Laboratories
- Forma Therapeutics
- fostamatinib
- Foundation Fighting Blindness
- Foundation Medicine
- Funding
- gasoline prices
- Gedeon Richter
- Gencaro
- gene therapy
- Genentech
- Generics
- genetic resources access and benefit
- Genome
- Genzyme
- George A. Scangos
- George Scangos
- George Washington Carver Award
- Geron
- Gilead Sciences
- GIST
- glaucoma
- GlaxoSmithKline
- Gleevec
- Global
- global food crisis
- Global Health
- Global Technology Portal
- globalization
- Governor Christie
- governors
- GSK
- GTx
- Guest Blog
- H3 Bioscience
- H5N1
- harmonization
- healtcare innovation
- Health
- Health Care
- healthcare
- heart disease
- hemophilia
- Hepatitis C
- Herceptin
- HIV
- HIV/AIDS
- Horizon Therapeutics
- Human Genome Sciences
- humanitarian
- Huntington's
- Ian Read
- Icagen
- Idenix Pharmaceuticals
- Idera Pharmaceuticals
- IDX184
- Illinois
- ImClone
- ImmunoGen
- ImmuPharma
- ImmusanT
- IMO-3100
- Impax Labs
- IMS Health
- Incivek
- Incyte
- index
- india
- industrial biotech
- industrial biotechnology
- industry
- industry trends
- infectious diseases
- Infinity Pharmaceuticals
- influentials
- Inhibitex
- Inlyta
- InnaVirVax
- innovation
- Inside BIO Industry Analysis
- Insmed
- insomnia
- Inspiration Biopharmaceuticals
- insulin
- Intellectual Property
- Intellectual Property Counsels' Committee
- Intellikine
- interferon
- Investment
- investor
- investors
- INX-189
- IP
- IPO
- Ipsen
- irisin
- Ironwood Pharmaceuticals
- Isis Pharmaceuticals
- J. Craig Venter
- JAK inhibitors
- Janssen
- Japan
- Jeb Bush
- Jeffrey Leiden
- Jeremy Levin
- Jim Greenwood
- Jim's Corner
- job creation
- job cuts
- jobs
- Joe Panetta
- John LaMattina
- John Lechleiter
- Johnson & Johnson
- JPM12
- Jubilant Biosys
- Julie Overbaugh
- Juvista
- Kalydeco
- Kansas Bioscience Authority
- Karo Bio
- Kathleen Sereda Glaub
- Kathryn Biberstein
- Kay Hagan
- Kenneth Frazier
- Kevin Sharer
- kidney cancer
- kidney disease
- kinase
- Kiran Mazumdar
- Kiran Mazumdar-Shaw
- Knome
- Korlym
- Krystexxa
- KV Pharmaceutical
- laquinimod
- Lars Rebien Sørensen
- Laura Shawver
- layoffs
- leadership
- legislation
- Legislators of the Year
- Lemtrada
- Len Blavatnik
- leukemia
- Leukemia & Lymphoma Society
- LibiGel
- license
- licensing
- Life Science
- life sciences
- Life Technologies
- Lipitor
- Liraglutide
- liver cancer
- lixisenatide
- lorcaserin
- Lou Gehrig's disease
- louisianna
- Lovenox
- Lucentis
- Lundbeck
- lung cancer
- LY2189265
- M&A
- macitentan
- MacroGenics
- macular degeneration
- manufacturing
- Marcadia
- Margaret Hamburg
- Marijn Dekkers
- Market Access
- Marketing
- Martin Mackay
- Mary Lynne Hedley
- maryland
- massachusetts
- Matt Emmens
- Matthew Emmens
- mayo clinic
- MDV3100
- Medarex
- Medical Devices
- Medical Economics
- Medical Education
- MedImmune
- MedImmune Ventures
- Medivation
- Melanoma
- Menopause
- Merck
- Merck KgAA
- Mergers and Acquisitions
- Merrimack Pharmaceuticals
- Mesoblast
- Metabolic disorders
- Miama
- Michael Budkie
- Michael Ryan
- MicroChips
- Micromet
- mifepristone
- military biofuel
- Miragen Therapeutics
- Missouri
- MIT
- MM&M
- Mnemosyne
- Molecular Partners
- Momenta Pharmaceuticals
- Moncef Slaoui
- monoclonal antibody
- MS
- Multaq
- multiple sclerosis
- Mundipharma International
- myelofibrosis
- Mylotarg
- Nasdaq Biotech Index
- National Institutes of Health
- Neratinib
- NeurogesX
- neuroscience
- new drugs
- New Enterprise Associates
- New Jersey
- new orleans
- NewLink Genetics
- Nexavar
- NICE
- NIH
- non-small cell lung cancer
- Northera
- Not-for-profit
- Novartis
- Novo Nordisk
- NVCA
- Nycomed
- obesity
- Odanacatib
- Okarios
- olaparib
- Omid Farokhzad
- Oncothyreon
- One-on-One's
- online communications
- Onyx Pharmaceuticals
- Open source R&D
- Orexigen Therapeutics
- orphan drug status
- Osiris Therapeutics
- osteoarthritis
- osteoporosis
- outsourcing
- ovarian cancer
- Oxford Bioscience Partners
- Oxyrane
- painkiller
- pancreatic cancer
- Paratek Pharmaceuticals
- Parkinson's
- Parkinson's
- Partnering
- patent
- Patent and Trademark Office
- patent application
- patent protection
- Patent Reform
- Patently BIOtech
- patents
- patient compliance
- Patrick Vallance
- Patriots
- payers
- PCI-32765
- PDUFA
- Pearl Therapeutics
- pediatric drug development
- Penicillin
- Peptimmune
- personalized medicine
- pertuzumab
- petroleum refiners
- Pfizer
- Pharmaceutical Patent
- Pharmaceuticals
- Pharmacyclics
- Pharmasset
- Phase III
- Phenomix Corporation
- PhRMA
- PI3-K
- Pixantrone
- placebo effect
- Plant biotechnology
- Plexxikon
- Pneumonia
- polio
- ponatinib
- Portola Pharmaceuticals
- prescription drugs
- Prevnar
- Prevnar 13
- Prezista
- primary care physicians
- PRIVATE BIOTECH
- Probiodrug
- Prochymal
- professional development
- Promacta
- Prosensa
- Prostate Cancer
- Protalix
- protein
- Proteolix
- Provenge
- PSI-7977
- PSI-938
- psilocybin
- psoriasis
- PTC Therapeutics
- PTO
- PUBLIC BIOTECH – Stats
- public health
- Public Policy
- pulmonary arterial hypertension
- Puma Biotechnology
- Purdue Pharma
- Qnexa
- Quintiles
- Qutenza
- QVA149
- R&D
- R&D budget
- R&D spending
- Radius Health
- Ranbaxy
- rare diseases
- Rasilez
- Rasitrio
- Reata Pharmaceuticals
- reexamination
- Regeneron Pharmaceuticals
- regorafenib
- regulation
- regulatory approvals
- REIMBURSEMENT
- Relovair
- renewable fuel standard
- Renovo
- Rep. England
- research
- Research and Development
- research grants
- Revascor
- Revlimid
- RFS
- Rib-X Pharmaceuticals
- Rituxan
- RNA
- RNAi
- Robert Bradway
- Robert Langer
- Roche
- Sagent Pharmaceuticals
- sale
- Salk
- Samsung
- San Diego
- San Francisco
- Sangamo BioSciences
- Sanofi
- Sanofi Pasteur
- Sanofi-Aventis
- Santhera
- Savient Pharmaceuticals
- sbir
- Schering-Plough
- schizophrenia
- Science
- Scotland
- Sean Harper
- SEL-068
- Selecta Biosciences
- Sen. Staton
- Senate
- Servier
- Severin Schwan
- Shire Pharmaceuticals
- Siga Technologies
- Silenor
- skin cancer
- small business
- Small Business Innovation Research
- small molecules
- Smallpox
- smoking cessation
- solanezumab
- Solvay Pharmaceuticals
- Somaxon
- Special 301
- spinal muscular atrophy
- Spinal Muscular Atrophy Foundation
- start up company
- startup
- Startups
- state government
- State of the Union
- states
- STEM
- Stem Cell Therapeutics
- Stem Cells
- STEM Education
- Stephen Simes
- Steve Jobs
- Steven Burrill
- Stimuvax
- stocks
- stomach cancer
- Strategy
- Stromedix
- students
- STX-100
- SuperGen
- Supply Chain
- Supreme Court
- Susan Desmond-Hellmann
- Susan Molineaux
- Sustainability
- Sutent
- Suvorexant
- Sygnis Pharma
- Synthetic biology
- T-DM1
- Tafamidis
- Takeda
- Targacept
- targeted therapies
- taspoglutide
- TC-5214
- teachers
- Technology
- Technology Transfer
- tedizolid
- Tekturna
- telaprevir
- teriflunomide
- Tetraphase Pharmaceuticals
- Teva Pharmaceutical Industries
- Texas
- Theraclone Sciences
- therapeutics
- Theratechnologies
- Theravance
- Third Rock Ventures
- Threshold Pharmaceuticals
- Tibotec
- tissue engineering
- tivozanib
- Tony West
- Tracleer
- training
- Transcept Pharmaceuticals
- Translational Sciences
- Tranzyme Pharma
- Tredaptive
- Trius Therapeutics
- Trophos
- Type 1 Diabetes
- Type 2 Diabetes
- Tysabri
- U.S. EPA
- U.S. Patent and Trademark Office
- u.s. politics
- U.S. Supreme Court
- UCSF
- underserved populations
- United Kingdom
- United States Patent and Trademark Office
- United States Trade Representative
- Universities
- University of Pennsylvania
- USPTO
- USTR
- vaccine
- vaccines
- Valeant Pharmaceuticals
- vandetanib
- Vascular Magnetics
- VC
- VC / M&A
- VEGF Trap-Eye
- vemurafenib
- Ventana
- venture
- venture capital
- Venture Capital fund
- venture funding
- venture money
- Verastem
- vertex
- Victoza
- Victrelis
- Videos
- Virginia
- visibility
- Vivus
- VLST
- vorapaxar
- Voraxaze
- VX-222
- Warp Drive Bio
- Watson Pharmaceuticals
- west virginia
- What would George do?
- women in bio
- Women in Biotech
- women in biotechnology
- World Health Organization
- World Pneumonia Day
- Wyeth
- Xalkori
- Xarelto
- Xenon
- Xgeva
- XL499
- Xoma
- XOMA 052
- Yervoy
- YM Biosciences
- ZafGen
- Zelboraf
- Zyprexa
Copyright © San Diego Biotech - Biotech Directory - Powered by WordPress